[PRESS RELEASE] – SMITHS FALLS, Ontario, Aug. 14, 2026 – Canopy Growth Corp., a leading global company committed to bettering lives through cannabis, announced that its Kincardine, Ontario, cultivation facility has received renewed European Union Good Manufacturing Practice (EU GMP) certification from the Regierungspräsidium Tübingen – Leitstelle Arzneimittelüberwachung Baden-Württemberg.
With its EU GMP status renewed, Canopy Growth can continue supplying Canadian-grown cannabis from Kincardine to medical cannabis markets across Europe.
“This renewal reflects the quality, consistency and reliability of our cultivation operations at Kincardine and our commitment to supplying high-quality EU GMP flower directly from Canada,” Canopy Growth CEO Luc Mongeau said. “As our business in Europe grows, we are continuing to broaden our flower portfolio, including through the introduction of MTL Cannabis genetics and additional strains, to meet the evolving needs of patients across the region.”
Kincardine is the anchor asset of Canopy Growth’s complete end-to-end EU GMP flower supply chain, connecting Canadian-cultivated flower to European distribution capabilities through Canopy Growth’s second EU GMP facility in Sankt Leon-Rot, Germany. Its renewed certification comes as the company continues to see momentum in Europe, which helped drive a 10% year-over-year increase in international cannabis net revenue in the first quarter of fiscal 2027.
